Portal de investigação
Hyperkalemia as a limiting factor of Neurohormonal Blockade/Modulation in everyday clinical practice
Dados básicos
- Código:
- Estudo Clínico Académico
- Protocolo:
- Estudo Clínico Académico
- EUDRACT:
- NCT:
- Centro:
- Dotação:
- Ano de início:
- 2020
- Ano de conclusão:
Objectivos do projeto
Estudos Observacionais (STROBE statement); Natureza do Promotor: Academia – Tipo não comercial – Iniciativa do Investigador; Tipo de Centro: Unicêntrico – Cuidados Secundários
Documentos
- Não há documentos
Participantes
Unidades de investigação
Stakeholders - Promotores
Outputs do ensaio clínico
Associations of medicine use and ejection fraction with the coexistence of frailty and sarcopenia in a sample of heart failure outpatients: a cross-sectional study
Valdiviesso, R.; (...); Borges, N.
Article. 10.1186/s12872-023-03632-x. 2023
conTemporary reflectiOns regarding heart failure manaGEmenT ? How to ovERcome the PorTuguese barriers (TOGETHER-PT); [Reflex?es contempor?neas sobre a gest?o da insufici?ncia card?aca ? Como ultrapassar as barreiras em Portugal]
Silva Cardoso, J.; (...); Pimenta, J.
Article. 10.1016/j.repc.2023.05.012. 2023
Current Use and Impact on 30-Day Mortality of Pulmonary Artery Catheter in Cardiogenic Shock Patients: Results From the CardShock Study
Sionis, A; (...); Masip, J
Article. 10.1177/0885066619828959. 2020
Effectiveness of Exercise-Based Cardiac Rehabilitation for Heart Transplant Recipients: A Systematic Review and Meta-Analysis
Costa, R; (...); Pinto, R
Review. 10.1177/11786329231161482. 2023
Effectiveness of Tele-rehabilitation Programs in Heart Failure: A Systematic Review and Meta-analysis
Cavalheiro, AH; (...); Azevedo, L.
Review. 10.1177/11786329211021668. 2021
Frailty phenotype and associated nutritional factors in a sample of Portuguese outpatients with heart failure
Valdiviesso, R.; (...); Borges, N.
Article. 10.1016/j.numecd.2021.03.028. 2021
Frailty phenotype in heart failure: A condition that transcends age
Valdiviesso, R; (...); Borges, N
Article. 10.1016/j.repc.2022.02.009. 2023
Global Variations in Heart Failure Etiology, Management, and Outcomes
Joseph, P; (...); Yusuf, S
Article. 10.1001/jama.2023.5942. 2023
Health-Related Quality of Life and Mortality in Heart Failure The Global Congestive Heart Failure Study of 23000 Patients From 40 Countries
Johansson, I; (...); Yusuf, S
Article. 10.1161/CIRCULATIONAHA.120.050850. 2021
Hyperkalemia as a limiting factor of neurohormonal blockade/modulation in everyday clinical practice
Vasconcelos, H; (...); Silva-Cardoso, J
Article. 10.1016/j.repc.2021.04.007. 2022
Kinetics of procalcitonin, C-reactive protein and interleukin-6 in cardiogenic shock - Insights from the CardShock study
Kataja, A; (...); Harjola, VP
Article. 10.1016/j.ijcard2020.08.069. 2021
Management of RAASi-associated hyperkalemia in patients with cardiovascular disease
Silva Cardoso, J.; (...); Fonseca, C
Article. 10.1007/s10741-020-10069-3. 2021
Mortality risk prediction in elderly patients with cardiogenic shock: results from the CardShock study
Hongisto, M; (...); Harjola, VP
Article. 10.1002/ehf2.13224. 2021
Optical Coherence Tomography Imaging of the Lamina Cribrosa: Structural Biomarkers in Nonglaucomatous Diseases
Paulo, A; (...); Barbosa Breda, J.
Article. 10.1155/2021/8844614. 2021
Optimization of heart failure with reduced ejection fraction prognosis-modifying drugs: A 2021 heart failure expert consensus paper
Silva Cardoso, J.; (...); Brito, D
Article. 10.1016/j.repc.2021.07.009. 2021
Portuguese adaptation of the Chronic Heart Failure Knowledge Questionnaire (KQCHF)
Azzam, AP; (...); Castro, S
Article. 10.1186/s12872-023-03325-5. 2023
Portuguese Heart Failure Prevalence Observational Study (PORTHOS) rationale and design - A population-based study
Baptista, R; (...); Gavina, C.
Article. 10.1016/j.repc.2023.10.004. 2023
Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal disease
Rossignol, P; (...); Butler, J
Editorial Material. 10.1016/j.phrs.2022.106277. 2022
Renin-angiotensin-aldosterone system inhibitors and the COVID-19 epidemic
Silva Cardoso, J., Moreira, E.
Editorial Material. 10.1016/j.repc.2022.08.006. 2022
Sacubitril/valsartan in everyday clinical practice: an observational study based on the experience of a heart failure clinic
Cabral, J; (...); Silva-Cardoso, J
Article. 10.21037/cdt-21-312. 2021
SGLT-2 inhibitors: A step forward in the treatment of heart failure with reduced ejection fraction
Silva Cardoso, J.; (...); Moura, B
Review. 10.1016/j.repc.2021.02.010. 2021
Socioeconomic Inequalities and Predictors of Cardiac Rehabilitation Referral: Real-World Evidence
Rocha, JA; (...); Cardoso, JCS
Article. 10.1097/PHM.0000000000002270. 2023
Soluble urokinase-type plasminogen activator receptor improves early risk stratification in cardiogenic shock
Hongisto, M; (...); Network, CSIATG
Article. 10.1093/ehjacc/zuac096. 2022
Statins are associated with reduced likelihood of sarcopenia in a sample of heart failure outpatients: a cross-sectional study
Valdiviesso, R.; (...); Borges, N.
Article. 10.1186/s12872-022-02804-5. 2022
The Future of Telemedicine in the Management of Heart Failure Patients
Silva Cardoso, J.; (...); Moreira, E.
Article. 10.15420/cfr.2020.32. 2021
Time-trends and predictors of interhospital transfers and 30-day rehospitalizations after acute coronary syndrome from 2000-2015
Rocha, JA; (...); Azevedo, L.
Article. 10.1371/journal.pone.0255134. 2021
UNIQUE DEVICE IDENTIFIERS FOR CARDIAC IMPLANTABLE ELECTRONIC DEVICES - A DATA QUALITY ASSESSMENT OF ADMINISTRATIVE HOSPITAL DATA IN PORTUGAL
Couto, S; (...); Freitas, A
Meeting Abstract. 2022
